An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
Clinical trial NCT02784158 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02784158
- Sponsor
- Ariad Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.